EcoDrugPlus

Prostaglandin I2 Receptor

Ensembl ID : ENSMMSG00000002087
Gene Symbol: PTGIR
1 Cross references
187 Possible Orthologues:

Prostaglandin-Endoperoxide Synthase 1

Ensembl ID : ENSMMSG00000003179
Gene Symbol: PTGS1
1 Cross references
256 Possible Orthologues:

Prostaglandin-Endoperoxide Synthase 2

Ensembl ID : ENSMMSG00000012858
Gene Symbol: PTGS2
1 Cross references
237 Possible Orthologues:

Proteasome 20s Subunit Alpha 1

Ensembl ID : ENSMMSG00000012625
Gene Symbol: PSMA1
1 Cross references
249 Possible Orthologues:

Proteasome 20s Subunit Alpha 2

Ensembl ID : ENSMMSG00000009746
Gene Symbol: PSMA2
1 Cross references
187 Possible Orthologues:

Proteasome 20s Subunit Alpha 3

Ensembl ID : ENSMMSG00000007088
Gene Symbol: PSMA3
1 Cross references
234 Possible Orthologues:

Proteasome 20s Subunit Alpha 4

Ensembl ID : ENSMMSG00000021439
Gene Symbol: PSMA4
1 Cross references
248 Possible Orthologues:

Proteasome 20s Subunit Alpha 5

Ensembl ID : ENSMMSG00000003976
Gene Symbol: PSMA5
1 Cross references
210 Possible Orthologues:

Proteasome 20s Subunit Alpha 6

Ensembl ID : ENSMMSG00000016417
Gene Symbol: PSMA6
1 Cross references
279 Possible Orthologues:

Proteasome 20s Subunit Alpha 7

Ensembl ID : ENSMMSG00000019883
Gene Symbol: PSMA7
1 Cross references
155 Possible Orthologues:

Proteasome 20s Subunit Alpha 8

Ensembl ID : ENSMMSG00000013624
Gene Symbol: PSMA8
1 Cross references
197 Possible Orthologues:

Proteasome 20s Subunit Beta 1

Ensembl ID : ENSMMSG00000005436
Gene Symbol: PSMB1
1 Cross references
216 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).